Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1522282 (
EMT
)
2,868
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ERp29
is a novel endoplasmic reticulum (ER) protein that plays an important role in protein unfolding and secretion. Recently, it has been reported to be widely implicated in control of tumorigenesis in some tumors. However, the potential function of
ERp29
in gastric cancer remains poorly understood. In this study, we found that the positive rate of
ERp29
in gastric cancer tissues was significantly lower than that in adjacent non-tumor tissues. And tumor with high
ERp29
expression had inclinations towards smaller tumor size and earlier TNM stage. The
in vitro
experiments indicated that over-expression of
ERp29
in gastric cancer cells significantly suppressed the proliferation and migration of tumor cells, which is consistent with the result of the
in vivo
animal experiments. Furthermore, our mechanistic investigations revealed that
ERp29
reversed
EMT
process in gastric carcinoma, and its effect was related to the inactivation of ERK1/2 and AKT phosphorylation. Thus, we conclude that
ERp29
acts as a tumor suppressor gene in gastric cancer, and is expected to become a novel target of the treatment of GC.
...
PMID:ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer. 2910 63